-- Results to date demonstrate rapid post-surgical visual recovery with no serious adverse events and meet or exceed FDA target rates for safety and effectiveness – -- Data presented today at ...
Vision recovery similar at 30 days, consistent with other recent randomized studies ...
Tornambe published experiences in 302 eyes, in which he found a single injection attachment rate of 68% and a final attachment rate after reoperations of 95%, with a minimum follow-up of 6 months. He ...